OBJECTIVE: To determine whether an independent association exists between anaemia and chronic kidney disease (CKD) outcomes in a quasi-incidence cohort when patients' most recent laboratory values are considered. METHODS: We conducted a dynamic, retrospective cohort study among patients with incident CKD in a large health maintenance organization administrative data set. CKD was defined by two estimated glomerular filtration rates (eGFR). We measured the absolute rates for all-cause mortality, cardiovascular hospitalizations and end-stage renal disease. RESULTS: Our completed cases Cox regression model followed 5885 patients with both CKD and haemoglobin measures. For patients with the most severe anaemia (haemoglobin <10.5 g/dL), we estimated an increased rate of mortality (hazard ratio (HR)=5.27, CI 4.37-6.35), cardiovascular hospitalizations (HR=2.18, CI 1.76-2.70) and end-stage renal disease (HR=5.46, CI 3.38-8.82) when compared with patients who were not anaemic; the HR reflect time-varying haemoglobins and eGFR. CONCLUSION: Anaemia is a predictor of excess mortality, excess cardiovascular hospitalizations and excess end-stage renal disease even when the progression of CKD is considered by controlling for time-varying eGFR values.
OBJECTIVE: To determine whether an independent association exists between anaemia and chronic kidney disease (CKD) outcomes in a quasi-incidence cohort when patients' most recent laboratory values are considered. METHODS: We conducted a dynamic, retrospective cohort study among patients with incident CKD in a large health maintenance organization administrative data set. CKD was defined by two estimated glomerular filtration rates (eGFR). We measured the absolute rates for all-cause mortality, cardiovascular hospitalizations and end-stage renal disease. RESULTS: Our completed cases Cox regression model followed 5885 patients with both CKD and haemoglobin measures. For patients with the most severe anaemia (haemoglobin <10.5 g/dL), we estimated an increased rate of mortality (hazard ratio (HR)=5.27, CI 4.37-6.35), cardiovascular hospitalizations (HR=2.18, CI 1.76-2.70) and end-stage renal disease (HR=5.46, CI 3.38-8.82) when compared with patients who were not anaemic; the HR reflect time-varying haemoglobins and eGFR. CONCLUSION:Anaemia is a predictor of excess mortality, excess cardiovascular hospitalizations and excess end-stage renal disease even when the progression of CKD is considered by controlling for time-varying eGFR values.
Authors: Teresa K Chen; Michelle M Estrella; Brad C Astor; Tom Greene; Xuelei Wang; Morgan E Grams; Lawrence J Appel Journal: Nephrol Dial Transplant Date: 2015-03-27 Impact factor: 5.992
Authors: Mark R Hanudel; Kristine Chua; Maxime Rappaport; Victoria Gabayan; Erika Valore; David Goltzman; Tomas Ganz; Elizabeta Nemeth; Isidro B Salusky Journal: Am J Physiol Renal Physiol Date: 2016-10-12
Authors: Alison G Abraham; Frank J Palella; Xiuhong Li; Michelle M Estrella; Lawrence A Kingsley; Mallory D Witt; Lisa P Jacobson Journal: AIDS Res Hum Retroviruses Date: 2012-06-29 Impact factor: 2.205
Authors: Mark R Hanudel; Michele F Eisenga; Maxime Rappaport; Kristine Chua; Bo Qiao; Grace Jung; Victoria Gabayan; Barbara Gales; Georgina Ramos; Maarten A de Jong; Jelmer J van Zanden; Martin H de Borst; Stephan J L Bakker; Elizabeta Nemeth; Isidro B Salusky; Carlo A J M Gaillard; Tomas Ganz Journal: Nephrol Dial Transplant Date: 2019-12-01 Impact factor: 5.992
Authors: Steven Fishbane; Mohamed A El-Shahawy; Roberto Pecoits-Filho; Bui Pham Van; Mark T Houser; Lars Frison; Dustin J Little; Nicolas J Guzman; Pablo E Pergola Journal: J Am Soc Nephrol Date: 2021-02-10 Impact factor: 10.121
Authors: Santosh L Saraf; Jesse Y Hsu; Ana C Ricardo; Rupal Mehta; Jing Chen; Teresa K Chen; Michael J Fischer; Lee Hamm; James Sondheimer; Matthew R Weir; Xiaoming Zhang; Myles Wolf; James P Lash Journal: Kidney360 Date: 2020-07-30